It’s the first Covid-19 shot to win full licensure in the United States.
The Food and Drug Administration has approved Pfizer and BioNTech’s Covid-19 vaccine for people 16 and older — making it the first to be fully licensed for use in the United States.
FDA’s decision to fully approve the shot will make it easier for universities, hospitals and other workplaces to require vaccination against the coronavirus, and it is a crucial step toward enabling the Biden administration’s plan to offer booster shots for adults beginning in September. Public health experts also hope the approval will convince a significant number of vaccine holdouts to get the shot, boosting the country’s vaccination rate as it battles the highly contagious Delta variant.
You must be logged in to reply to this topic.